University of California San Francisco

Melisa Wong 134
Melisa L. Wong, MD, MAS

Assistant Clinical Professor
Division of Hematology/Oncology
Department of Medicine

Address

490 Illinois Street, #8224
San Francisco, CA 94158
United States

ORCID: 0000-0001-6390-6959

Biography

Melisa Wong, MD, MAS, AGSF is a thoracic oncologist who treats patients with lung cancer and other thoracic malignancies. Dr. Wong has a particular interest in caring for older adults with cancer. Her goal is to provide personalized cancer care based on patients’ values and goals.

Dr. Wong’s research focuses on understanding and improving patient-centered outcomes in older adults with cancer. She and her research team study the impact of lung cancer treatment on patients’ functional status and quality of life.

In 2005, Dr. Wong earned her undergraduate degree in Human Biology with Honors and Distinction at Stanford University. She then completed medical school and training in internal medicine and medical oncology at UCSF. Dr. Wong also completed advanced research training as an Aging Research Fellow in the UCSF Division of Geriatrics and earned her Master’s Degree in Clinical Research in the UCSF Department of Epidemiology and Biostatistics. Dr. Wong is a member of the American Society of Clinical Oncology, Cancer and Aging Research Group, Alliance for Clinical Trials in Oncology, International Society of Geriatric Oncology, International Association for the Study of Lung Cancer, and American Geriatrics Society.

Dr. Wong was a National Institute on Aging Butler-Williams Scholar in 2016 and received four Conquer Cancer Foundation of ASCO Merit Awards (2016 and 2017 ASCO Quality Care Symposium, 2016 and 2017 ASCO Annual Meeting). In 2017, she also received a Conquer Cancer Foundation of ASCO/Vicky Merryman Women Who Conquer Cancer Young Investigator Award, UCSF Claude D. Pepper Older Americans Independence Center Research Education Core Advanced Scholar Award, UCSF CTSI KL2 Career Development Award, and NIA GEMSSTAR R03. Dr. Wong's geriatric oncology research program is currently funded by an NIA Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76).

Awards & Honors

Award Conferred By Date
Geriatric Oncology Community of Practice Co-Chair ASCO 2022
Dr. Arti Hurria Best Paper Award Journal of Geriatric Oncology 2022
Geriatric Oncology Education Committee ASCO 2021
Editorial Board Member Journal of Geriatric Oncology 2021
Cancer and Aging Special Interest Group Chair American Geriatrics Society 2018/2020
Early Career Faculty Workgroup Claude D. Pepper Older Americans Independence Center 2018/2020
Junior Investigator Board Cancer and Aging Research Group 2018
Loan Repayment Program Award NIH/NCI 2017/2020
Vicky Merryman Women Who Conquer Cancer Young Investigator Award Conquer Cancer Foundation of ASCO 2017/2018
Merit Award - Annual Meeting Conquer Cancer Foundation of ASCO 2017
Merit Award - Quality Care Symposium Conquer Cancer Foundation of ASCO 2017
SIOG Young Investigator Award International Society of Geriatric Oncology (SIOG) 2017
Merit Award - Annual Meeting Conquer Cancer Foundation of ASCO 2016
Merit Award - Quality Care Symposium Conquer Cancer Foundation of ASCO 2016
Butler-Williams Scholars Program National Institute on Aging 2016
Hematology/Oncology Chief Fellow UCSF 2016
Hematology/Oncology Division Clinical Fellow Award UCSF Department of Medicine 2016
Award for Excellence in Fellowship Research UCSF Hematology/Oncology Research Retreat 2016
Cancer and Aging Research U13 Conference Young Investigator Travel Award Cancer and Aging Research Group 2015
Hematology/Oncology Quality Chief Fellow UCSF 2015
Department of Medicine Professionalism Award UCSF 2014
SOM Dean's Quarterly Research Fellowship UCSF 2011
Alpha Omega Alpha Honor Medical Society UCSF 2010
Bernard Osher Scholarship UCSF 2008/2011
SOM Dean's Summer Research Fellowship UCSF 2008
Joshua Lederberg Award for Academic Excellence in Human Biology Stanford University 2005
Chappell Lougee Scholarship Stanford University 2003

Education

Institution Degree Dept or School End Date
UCSF Master's Degree Program in Clinical Research Division of Epidemiology & Biostatistics 2017
UCSF Aging Research T32 Fellowship Division of Geriatrics 2017
UCSF Medical Oncology Fellowship Division of Hematology/Oncology 2016
UCSF Internal Medicine Residency Department of Medicine 2014
UCSF MD School of Medicine 2011
Stanford University BA Human Biology 2005

Board Certifications

American Board of Internal Medicine, Internal Medicine
American Board of Internal Medicine, Medical Oncology

Clinical Expertise

Non-Small Cell Lung Cancer

Small Cell Lung Cancer

Geriatric Oncology

 

Program Affiliations

Department of Medicine, Division of Hematology/Oncology

Thoracic Oncology Program

UCSF Helen Diller Family Comprehensive Cancer Center

Grants and Funding

  • Enhancing the “Lung cancer in older adults: Treatment experience through the patient’s lens” cohort study | UCSF Department of Medicine Cohort Grant | 2022-07-01 - 2024-06-30 | Role:
  • Advancing patient-centered decision making in older adults with lung cancer: Incorporating risk of functional decline into treatment discussions | NIH/NIA | 2019-07-15 - 2024-02-29 | Role:
  • Mixed methods evaluation of the Best Case/Worst Case-Geriatric Oncology communication tool | UCSF Claude D. Pepper Older Americans Independence Center Pilot & Exploratory Studies Core Scholar Award | 2022-07-01 - 2023-06-30 | Role:
  • Feasibility pilot study of the Best Case/Worst Case-Geriatric Oncology communication tool to improve decision making for older adults with advanced cancer | Mount Zion Health Fund | 2022-07-01 - 2023-06-30 | Role:
  • Adaptation of the Best Case/Worst Case communication tool to geriatric oncology: Improving patient-centered decision making for older adults with lung cancer | Helen Diller Family Comprehensive Cancer Center-Mount Zion Health Fund Pilot for Junior Investigators in Basic and Clinical/Translational Sciences | 2019-07-01 - 2020-06-30 | Role:
  • UCSF CTSI KL2 Career Development Award | NIH/NCATS | 2017-07-01 - 2020-05-31 | Role: KL2 Scholar
  • Expanding the Definition of Treatment Toxicity in Older Adults with Lung Cancer | NIH/NIA | 2017-07-01 - 2020-05-31 | Role: Principal Investigator
  • UCSF Older Americans Independence Center Research Advanced Scholar Award | NIH/NIA | 2017-07-01 - 2019-06-30 | Role: Research Education Core Advanced Scholar
  • Characterization of chemotherapy-induced peripheral neuropathy in older cancer survivors | Conquer Cancer Foundation of ASCO/Vicky Merryman Women Who Conquer Cancer Young Investigator Award | 2017-07-01 - 2018-06-30 | Role:

Research Narrative

Dr. Wong's research focuses on understanding and improving patient-centered outcomes in older adults with cancer. She is currently studying the impact of lung cancer treatment (such as chemotherapy, immunotherapy, and targeted therapy) on patients' functional status and quality of life. Dr. Wong also studies how symptoms change over time in older adults with cancer. 

Dr. Wong’s forthcoming study, “Lung Cancer in Older Adults: Treatment Toxicity Through the Patient’s Lens,” will recruit UCSF lung cancer patients who are age 65 or older and starting a new chemotherapy, immunotherapy, or targeted therapy regimen. Dr. Wong and her research team will explore how lung cancer treatment impacts patients’ functional status and quality of life.  

Research Interests

Geriatric oncology

Functional status

Quality of life

Treatment toxicity

Cancer outcomes research

 

Publications

MOST RECENT PUBLICATIONS FROM A TOTAL OF 63
  1. Perturbations in inflammatory pathways are associated with shortness of breath profiles in oncology patients receiving chemotherapy.
    Shin J, Miaskowski C, Wong ML, Yates P, Olshen AB, Roy R, Dokiparthi V, Cooper B, Paul S, Conley YP, Levine JD, Hammer MJ, Kober K| | View in PubMed
  2. Receipt of financial assistance for oral targeted therapy among older adults with advanced non-small cell lung cancer: A prospective cohort study.
    Kumar A, Ragavan M, Velazquez AI, Zeng S, Wong ML| | View in PubMed
  3. Evaluation of Culture Conducive to Academic Success by Gender at a Comprehensive Cancer Center.
    Keenan BP, Sibley A, Zhang L, Westring AF, Velazquez AI, Bank EM, Bergsland EK, Boreta L, Conroy P, Daras M, Hermiston M, Hsu G, Paris PL, Piawah S, Sinha S, Sosa JA, Tsang M, Venook AP, Wong M, Yom SS, Van Loon K| | View in PubMed
  4. Stability and consistency of symptom clusters in younger versus older patients receiving chemotherapy.
    Morse L, Cooper BA, Ritchie CS, Wong ML, Kober KM, Harris C, Shin J, Oppegaard K, Hammer MJ, Schimmel AC, Paul SM, Conley YP, Levine JD, Miaskowski C| | View in PubMed
  5. Evaluation of venous thromboembolism prophylaxis protocol in hematopoietic cell transplant patients.
    Lee A, Badgley C, Lo M, Banez MT, Graff L, Damon L, Martin T, Dzundza J, Wong M, Olin R| | View in PubMed
  6. Higher Lifetime Stress and Symptom Burden Contribute to the Occurrence of Shortness of Breath.
    Shin J, Kober K, Yates P, Wong ML, Cooper BA, Paul SM, Hammer M, Conley Y, Levine JD, Wright F, Miaskowski C| | View in PubMed
  7. Age-related differences in cancer relative survival in the United States: A SEER-18 analysis.
    Withrow DR, Nicholson BD, Morris EJA, Wong ML, Pilleron S| | View in PubMed
  8. Osimertinib in NSCLC With Atypical EGFR-Activating Mutations: A Retrospective Multicenter Study.
    Ji J, Aredo JV, Piper-Vallillo A, Huppert L, Rotow JK, Husain H, Stewart S, Cobb R, Wakelee HA, Blakely CM, Wong ML, Gubens MA, Madani MH, Digumarthy SR, McCoach C, Piotrowska Z, Neal JW, Riess JW| | View in PubMed
  9. Integrating Geriatric Assessment Measures into National Cancer Institute Clinical Trials.
    Magnuson A, Van der Walde N, McKoy JM, Wildes TM, Wong ML, Le-Rademacher J, Little RF, Klepin HD| | View in PubMed
  10. Distinct Shortness of Breath Profiles in Oncology Outpatients Undergoing Chemotherapy.
    Shin J, Kober KM, Wong ML, Yates P, Cooper BA, Paul SM, Hammer M, Conley Y, Levine JD, Miaskowski C| | View in PubMed
  11. Systematic review of the literature on the occurrence and characteristics of dyspnea in oncology patients.
    Shin J, Kober K, Wong ML, Yates P, Miaskowski C| | View in PubMed
  12. Adapting a patient-centered communication tool for older patients with acute myeloid leukemia and their oncologist.
    Watson E, Sanapala C, Cortes AM, Klepin HD, Wittink M, Norton S, Richardson DR, Dale W, Magnuson A, Mendler JH, Liesveld J, Huselton E, O'Dwyer K, LeBlanc TW, El-Jawahri A, Wong ML, Loh KP| | View in PubMed
  13. The epidemiology of preexisting geriatric and palliative conditions in older adults with poor prognosis cancers.
    Tsang M, Gan S, Boscardin WJ, Wong ML, Walter LC, Smith AK| | View in PubMed
  14. Change in four measures of physical function among older adults during lung cancer treatment: A mixed methods cohort study.
    Singhal S, Walter LC, Smith AK, Loh KP, Cohen HJ, Zeng S, Shi Y, Boscardin WJ, Presley CJ, Williams GR, Magnuson A, Mohile SG, Wong ML| | View in PubMed
  15. Survive and thrive: Personal stories of persistence and resilience in aging research.
    Wong ML, Brown CJ, Kitzman DW, Zeng S, Mohile SG| | View in PubMed
  16. Functional Trajectories and Resilience Among Adults With Advanced Lung Cancer.
    Presley CJ, Arrato NA, Shields PG, Carbone DP, Wong ML, Benedict J, Reisinger SA, Han L, Gill TM, Allore H, Andersen BL, Janse S| | View in PubMed
  17. A Geriatric Assessment Intervention to Reduce Treatment Toxicity Among Older Adults With Advanced Lung Cancer: A Subgroup Analysis From a Cluster Randomized Controlled Trial.
    Presley CJ, Mohamed MR, Culakova E, Flannery M, Vibhakar PH, Hoyd R, Amini A, VanderWalde N, Wong ML, Tsubata Y, Spakowicz DJ, Mohile SG| | View in PubMed
  18. "You have to be sure that the patient has the full picture": Adaptation of the Best Case/Worst Case communication tool for geriatric oncology.
    Wong ML, Nicosia FM, Smith AK, Walter LC, Lam V, Cohen HJ, Loh KP, Mohile SG, Ursem CJ, Schwarze ML| | View in PubMed
  19. Changes in older adults' life space during lung cancer treatment: A mixed methods cohort study.
    Wong ML, Shi Y, Smith AK, Miaskowski C, Boscardin WJ, Cohen HJ, Lam V, Mazor M, Metzger L, Presley CJ, Williams GR, Loh KP, Ursem CJ, Friedlander TW, Blakely CM, Gubens MA, Allen G, Shumay D, Walter LC| | View in PubMed
  20. Immunotherapy in Older Adults With Cancer.
    Presley CJ, Gomes F, Burd CE, Kanesvaran R, Wong ML| | View in PubMed
  21. Functional Disability Among Older Versus Younger Adults With Advanced Non-Small-Cell Lung Cancer.
    Presley CJ, Arrato NA, Janse S, Shields PG, Carbone DP, Wong ML, Han L, Gill TM, Allore HG, Andersen BL| | View in PubMed
  22. Characteristics Associated With Functional Changes During Systemic Cancer Treatments: A Systematic Review Focused on Older Adults.
    Loh KP, Lam V, Webber K, Padam S, Sedrak MS, Musinipally V, Grogan M, Presley CJ, Grandi J, Sanapala C, Castillo DA, DiGiovanni G, Mohile SG, Walter LC, Wong ML| | View in PubMed
  23. Expanding Beyond Maximum Grade: Chemotherapy Toxicity over Time by Age and Performance Status in Advanced Non-Small Cell Lung Cancer in CALGB 9730 (Alliance A151729).
    Wong ML, Gao J, Thanarajasingam G, Sloan JA, Dueck AC, Novotny PJ, Jatoi A, Hurria A, Walter LC, Miaskowski C, Cohen HJ, Wood WA, Feliciano JL, Stinchcombe TE, Wang X| | View in PubMed
  24. Toxicity and survival outcomes in older adults receiving concurrent or sequential chemoradiation for stage III non-small cell lung cancer in Alliance trials (Alliance A151812).
    Maggiore RJ, Zahrieh D, McMurray RP, Feliciano JL, Samson P, Mohindra P, Chen H, Wong ML, Lafky JM, Jatoi A, Le-Rademacher JG| | View in PubMed
  25. Evaluation of a National Comprehensive Cancer Network Guidelines-Based Decision Support Tool in Patients With Non-Small Cell Lung Cancer: A Nonrandomized Clinical Trial.
    Wu SY, Lazar AA, Gubens MA, Blakely CM, Gottschalk AR, Jablons DM, Jahan TM, Wang VEH, Dunbar TL, Wong ML, Chan JW, Guthrie W, Belkora J, Yom SS| | View in PubMed
  26. Co-occurrence of decrements in physical and cognitive function is common in older oncology patients receiving chemotherapy.
    Utne I, Cooper BA, Ritchie C, Wong M, Dunn LB, Loyland B, Grov EK, Hammer MJ, Paul SM, Levine JD, Conley YP, Kober KM, Miaskowski C| | View in PubMed
  27. Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion Update.
    Hwang JP, Feld JJ, Hammond SP, Wang SH, Alston-Johnson DE, Cryer DR, Hershman DL, Loehrer AP, Sabichi AL, Symington BE, Terrault N, Wong ML, Somerfield MR, Artz AS| | View in PubMed
  28. Immunotherapy in older patients with non-small cell lung cancer: Young International Society of Geriatric Oncology position paper.
    Gomes F, Wong M, Battisti NML, Kordbacheh T, Kiderlen M, Greystoke A, Luciani A| | View in PubMed
  29. Associations of Caregiver-Oncologist Discordance in Prognostic Understanding With Caregiver-Reported Therapeutic Alliance and Anxiety.
    Loh KP, Xu H, Epstein RM, Mohile SG, Prigerson HG, Plumb S, Ladwig S, Kadambi S, Wong ML, McHugh C, An A, Trevino K, Saeed F, Duberstein PR| | View in PubMed
  30. Predicting risk of chemotherapy-induced severe neutropenia: A pooled analysis in individual patients data with advanced lung cancer.
    Cao X, Ganti AK, Stinchcombe T, Wong ML, Ho JC, Shen C, Liu Y, Crawford J, Pang H, Wang X| | View in PubMed
  31. Geriatric oncology health services research: Cancer and Aging Research Group infrastructure core.
    Wong ML, Lichtman SM, Morrow GR, Simmons J, Hargraves T, Gross CP, Lund JL, Lowenstein LM, Walter LC, McDermott CL, Mohile SG, Cohen HJ| | View in PubMed
  32. Co-occuring symptoms in older oncology patients with distinct attentional function profiles.
    Utne I, Løyland B, Grov EK, Paul S, Wong ML, Conley YP, Cooper BA, Levine JD, Miaskowski C| | View in PubMed
  33. Geriatric oncology research at the 2019 American Geriatrics Society (AGS) annual meeting: Joint perspectives from the Young International Society of Geriatric Oncology (SIOG) and AGS Cancer and Aging Special Interest Group.
    Kotwal AA, Presley CJ, Loh KP, Huang LW, Lam V, Wong ML| | View in PubMed
  34. Arti Hurria, M.D.: A tribute to her shining legacy in the Alliance for Clinical Trials in Oncology.
    Alliance Cancer in the Older Adult Committee:, Adjei A, Buckner JC, Cathcart-Rake E, Chen H, Cohen HJ, Dao D, De Luca JE, Feliciano J, Freedman RA, Goldberg RM, Hopkins J, Hubbard J, Jatoi A, Karuturi M, Kemeny M, Kimmick GG, Klepin HD, Krok-Schoen JL, Lafky JM, Le-Rademacher JG, Li D, Lichtman SM, Maggiore R, Mandelblatt J, Morrison VA, Muss HB, Ojelabi MO, Sedrak MS, Subbiah N, Sun V, Tuttle S, VanderWalde N, Wildes T, Wong ML, Woyach J| | View in PubMed
  35. Mentoring pearls of wisdom: Lessons learned by mentees of Arti Hurria, MD.
    Magnuson A, Li D, Hsu T, Loh KP, MacKenzie A, Presley CJ, Krok-Schoen JL, Subbiah IM, Williams GR, Wong M, Soto-Perez-de-Celis E, Sedrak MS, Junior Cancer and Aging Research Group| | View in PubMed
  36. Who Will Care for the Caregivers? Increased Needs When Caring for Frail Older Adults With Cancer.
    Huang LW, Smith AK, Wong ML| | View in PubMed
  37. Age-related differences in patient-reported and objective measures of chemotherapy-induced peripheral neuropathy among cancer survivors.
    Wong ML, Cooper BA, Paul SM, Abrams G, Topp K, Kober KM, Chesney MA, Mazor M, Schumacher MA, Conley YP, Levine JD, Miaskowski C| | View in PubMed
  38. Stability of Symptom Clusters in Patients With Lung Cancer Receiving Chemotherapy.
    Russell J, Wong ML, Mackin L, Paul SM, Cooper BA, Hammer M, Conley YP, Wright F, Levine JD, Miaskowski C| | View in PubMed
  39. From clinical trials to real-world practice: Immune checkpoint inhibitors in older adults.
    Loh KP, Wong ML, Maggiore R| | View in PubMed
  40. Going Far Together: A Tribute to Arti Hurria, MD.
    Wong ML, Cohen HJ| | View in PubMed
  41. More Frequent Surveillance Following Lung Cancer Resection Is Not Associated With Improved Survival: A Nationally Representative Cohort Study.
    McMurry TL, Stukenborg GJ, Kessler LG, Colditz GA, Wong ML, Francescatti AB, Jones DR, Schumacher JR, Greenberg CC, Chang GJ, Winchester DP, McKellar DP, Kozower BD| | View in PubMed
  42. Comorbidity Assessment in the National Cancer Database for Patients With Surgically Resected Breast, Colorectal, or Lung Cancer (AFT-01, -02, -03).
    Wong ML, McMurry TL, Schumacher JR, Hu CY, Stukenborg GJ, Francescatti AB, Greenberg CC, Chang GJ, McKellar DP, Walter LC, Kozower BD| | View in PubMed
  43. Characteristics Associated With Physical Function Trajectories in Older Adults With Cancer During Chemotherapy.
    Wong ML, Paul SM, Mastick J, Ritchie C, Steinman MA, Walter LC, Miaskowski C| | View in PubMed
  44. Distinct attentional function profiles in older adults receiving cancer chemotherapy.
    Utne I, Løyland B, Grov EK, Rasmussen HL, Torstveit AH, Cooper BA, Mastick J, Mazor M, Wong M, Paul SM, Conley YP, Jahan T, Ritchie C, Levine JD, Miaskowski C| | View in PubMed
  45. Age, comorbidity, life expectancy, and pulmonary nodule follow-up in older veterans.
    Wong ML, Shi Y, Fung KZ, Ngo S, Elicker BM, Brown JK, Hiatt RA, Tang VL, Walter LC| | View in PubMed
  46. Individualizing PSA Monitoring Among Older Prostate Cancer Survivors.
    Shi Y, Fung KZ, John Boscardin W, Ngo S, Freedland SJ, Wong ML, Walter LC| | View in PubMed
  47. Time-to-Treatment-Failure and Related Outcomes Among 1000+ Advanced Non-Small Cell Lung Cancer Patients: Comparisons Between Older Versus Younger Patients (Alliance A151711).
    Gajra A, Zemla TJ, Jatoi A, Feliciano JL, Wong ML, Chen H, Maggiore R, McMurray RP, Hurria A, Muss HB, Cohen HJ, Lafky J, Edelman MJ, Lilenbaum R, Le-Rademacher JG| | View in PubMed
  48. Distinct Physical Function Profiles in Older Adults Receiving Cancer Chemotherapy.
    Miaskowski C, Wong ML, Cooper BA, Mastick J, Paul SM, Possin K, Steinman M, Cataldo J, Dunn LB, Ritchie C| | View in PubMed
  49. Differences in Symptom Clusters Identified Using Ratings of Symptom Occurrence vs. Severity in Lung Cancer Patients Receiving Chemotherapy.
    Wong ML, Cooper BA, Paul SM, Levine JD, Conley YP, Wright F, Hammer M, Miaskowski C| | View in PubMed
  50. Predictors of the multidimensional symptom experience of lung cancer patients receiving chemotherapy.
    Wong ML, Paul SM, Cooper BA, Dunn LB, Hammer MJ, Conley YP, Wright F, Levine JD, Walter LC, Cartwright F, Miaskowski C| | View in PubMed
  51. Chemotherapy-Induced Neuropathy in Cancer Survivors.
    Miaskowski C, Mastick J, Paul SM, Topp K, Smoot B, Abrams G, Chen LM, Kober KM, Conley YP, Chesney M, Bolla K, Mausisa G, Mazor M, Wong M, Schumacher M, Levine JD| | View in PubMed
  52. Impact of age and comorbidity on treatment of non-small cell lung cancer recurrence following complete resection: A nationally representative cohort study.
    Wong ML, McMurry TL, Stukenborg GJ, Francescatti AB, Amato-Martz C, Schumacher JR, Chang GJ, Greenberg CC, Winchester DP, McKellar DP, Walter LC, Kozower BD| | View in PubMed
  53. Enrollment Trends and Disparity Among Patients With Lung Cancer in National Clinical Trials, 1990 to 2012.
    Pang HH, Wang X, Stinchcombe TE, Wong ML, Cheng P, Ganti AK, Sargent DJ, Zhang Y, Hu C, Mandrekar SJ, Redman MW, Manola JB, Schilsky RL, Cohen HJ, Bradley JD, Adjei AA, Gandara D, Ramalingam SS, Vokes EE| | View in PubMed
  54. Chemotherapy-related cognitive impairment in older patients with cancer.
    Loh KP, Janelsins MC, Mohile SG, Holmes HM, Hsu T, Inouye SK, Karuturi MS, Kimmick GG, Lichtman SM, Magnuson A, Whitehead MI, Wong ML, Ahles TA| | View in PubMed
  55. Understanding cognition in older patients with cancer.
    Karuturi M, Wong ML, Hsu T, Kimmick GG, Lichtman SM, Holmes HM, Inouye SK, Dale W, Loh KP, Whitehead MI, Magnuson A, Hurria A, Janelsins MC, Mohile S| | View in PubMed
  56. Clinician Factors Associated With Prostate-Specific Antigen Screening in Older Veterans With Limited Life Expectancy.
    Tang VL, Shi Y, Fung K, Tan J, Espaldon R, Sudore R, Wong ML, Walter LC| | View in PubMed
  57. Incidence of non-small-cell lung cancer among California Hispanics according to neighborhood socioeconomic status.
    Wong ML, Clarke CA, Yang J, Hwang J, Hiatt RA, Wang S| | View in PubMed
  58. Discovery of a potent small-molecule antagonist of inhibitor of apoptosis (IAP) proteins and clinical candidate for the treatment of cancer (GDC-0152).
    Flygare JA, Beresini M, Budha N, Chan H, Chan IT, Cheeti S, Cohen F, Deshayes K, Doerner K, Eckhardt SG, Elliott LO, Feng B, Franklin MC, Reisner SF, Gazzard L, Halladay J, Hymowitz SG, La H, LoRusso P, Maurer B, Murray L, Plise E, Quan C, Stephan JP, Young SG, Tom J, Tsui V, Um J, Varfolomeev E, Vucic D, Wagner AJ, Wallweber HJ, Wang L, Ware J, Wen Z, Wong H, Wong JM, Wong M, Wong S, Yu R, Zobel K, Fairbrother WJ| | View in PubMed
  59. Impact of age and comorbidity on non-small-cell lung cancer treatment in older veterans.
    Wang S, Wong ML, Hamilton N, Davoren JB, Jahan TM, Walter LC| | View in PubMed
  60. More to mutton than meets the eye.
    Pierce RG, Wong M, Skalet AB| | View in PubMed
  61. Children's perceived social support after a parent is diagnosed with cancer.
    Wong M, Ratner J, Gladstone KA, Davtyan A, Koopman C| | View in PubMed
  62. Posttraumatic growth and adverse long-term effects of parental cancer in children.
    Wong ML, Cavanaugh CE, Macleamy JB, Sojourner-Nelson A, Koopman C| | View in PubMed
  63. A preliminary study of peritraumatic dissociation, social support, and coping in relation to posttraumatic stress symptoms for a parent's cancer.
    Wong M, Looney E, Michaels J, Palesh O, Koopman C| | View in PubMed